RBC Capital Maintains Sector Perform on Dialogue Health Tech, Lowers Price Target to C$5
RBC Capital analyst Douglas Miehm maintains Dialogue Health Tech (TSX:CARE) with a Sector Perform and lowers the price target from C$6 to C$5.
RBC Capital Maintains Sector Perform on Dialogue Health Tech, Lowers Price Target to C$6
RBC Capital analyst Douglas Miehm maintains Dialogue Health Tech (TSX:CARE) with a Sector Perform and lowers the price target from C$7 to C$6.
RBC Capital Raises Dialogue Health Technologies Price Target, Positive On Recent Acquisition
RBC Capital analyst Douglas Miehm raised the price target for Dialogue Health Technologies Inc (TSX: CARE) to C$10 from C$9 with the Sector Perform rating on the shares.
RBC Capital Maintains Sector Perform on Dialogue Health Tech, Raises Price Target to C$10
RBC Capital analyst Douglas Miehm maintains Dialogue Health Tech (TSX:CARE) with a Sector Perform and raises the price target from C$9 to C$10.
RBC Capital Maintains Sector Perform on Dialogue Health Tech, Lowers Price Target to C$12
RBC Capital analyst Douglas Miehm maintains Dialogue Health Tech (TSX:CARE) with a Sector Perform and lowers the price target from C$14 to C$12.